Regadenoson
NDC 0409-1401, Regadenoson, injection, solution, from Hospira, Inc..
- Product NDC
- 0409-1401
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214349
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON ANHYDROUS.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0409-1401-01 | 00409140101 | 10 CARTON in 1 PACKAGE (0409-1401-01) / 1 SYRINGE, PLASTIC in 1 CARTON / 5 mL in 1 SYRINGE, PLASTIC (0409-1401-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/0e3f080d-b1fb-47ed-8cd3-90a4206fa704Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0409-1401
Use it
Look up 0409-1401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0409-1401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.